Literature DB >> 324338

Lymphocyte depression by cancer.

A J Edwards.   

Abstract

We believe we have shown in the animal model that in cancer the host's lymphoreticular tissues are engaged by a systemically disseminated antilymphocytic humoral factor that destroys the T-cell-dependent pathway, allowing the dissemination of the disease that results in the death of the animal. From studies on patients with cancer there appears to be a real possibility of the presence of a similar substance in man. Such a factor may form the basis for the definiation of cancer and an explanation of cancer illness on the runt hypothesis. Moreover, if the factor could be identified and antagonized a major therapeutic advantage would be achieved.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324338      PMCID: PMC2491759     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  29 in total

1.  Immunological enhancement of tumor homografts in mice: a review.

Authors:  N KALISS
Journal:  Cancer Res       Date:  1958-10       Impact factor: 12.701

2.  A simple method for inducing tolerance of skin homografts in mice.

Authors:  R E BILLINGHAM; L BRENT
Journal:  Transplant Bull       Date:  1957-04

3.  In vitro study of cellular immunity against autochthonous human cancer.

Authors:  A Segall; O Weiler; J Genin; J Lacour; F Lacour
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

4.  Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer.

Authors:  A J Edwards; G F Rowland; M R Lee
Journal:  Lancet       Date:  1973-03-31       Impact factor: 79.321

5.  Lymphocyte transformation in cancer patients.

Authors:  C Hagen; A Froland; E Weberg
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

6.  Reduced lymphocyte transformation in breast cancer.

Authors:  M G Whittaker; K Rees; C G Clark
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

7.  Effect of homologous plasma on lymphocyte transformation in cancer patients and controls.

Authors:  M al-Sarraf; V K Vaitkevicius
Journal:  Lancet       Date:  1971-08-07       Impact factor: 79.321

8.  The delayed hypersensitivity reaction in breast cancer.

Authors:  M M Roberts; W Jones-Williams
Journal:  Br J Surg       Date:  1974-07       Impact factor: 6.939

9.  Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer.

Authors:  R M Sutherland; W R Inch; J A McCredie
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

10.  Immunosuppressive effect of surgery.

Authors:  S K Park; J I Brody; H A Wallace; W S Blakemore
Journal:  Lancet       Date:  1971-01-09       Impact factor: 79.321

View more
  1 in total

1.  Clinical and in vivo response following surgery or surgery plus adjuvant chemotherapy or immunotherapy for colorectal carcinoma in a rat model.

Authors:  A K House; M A Maley
Journal:  J R Soc Med       Date:  1983-10       Impact factor: 18.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.